Dietary Flavonoid and Lignan Intake and Mortality in Prospective Cohort Studies: Systematic Review and Dose-Response Meta-Analysis

American Journal of Epidemiology

Volumn 185, Issue 12, 2017, Pages 1304-1316

  Grosso, Giuseppe ^a,b   Micek, Agnieszka ^c   Godos, Justyna ^b,d   Pajak, Andrzej ^c   Sciacca, Salvatore ^b   Galvano, Fabio ^d   Giovannucci, Edward L ^e,f  

^a ST JOHN S COLLEGE   (United Kingdom)

^b UNIVERSITY OF MESSINA   (Italy)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d UNIVERSITY OF CATANIA   (Italy)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

all cause mortality; cardiovascular disease mortality; flavonoids; lignans; meta analysis; prospective studies

Indexed keywords

CATECHIN; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; HESPERETIN; ISOFLAVONE DERIVATIVE; KAEMPFEROL; LIGNAN; MYRICETIN; NARINGENIN; PROANTHOCYANIDIN DERIVATIVE; QUERCETIN;

CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DOSE-RESPONSE RELATIONSHIP; FOOD INTAKE; HEALTH RISK; LITERATURE REVIEW; META-ANALYSIS; MORTALITY; PHENOLIC COMPOUND; PIGMENT;

ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; DIETARY INTAKE; EDUCATIONAL STATUS; HUMAN; META ANALYSIS; MORTALITY; MORTALITY RISK; QUANTITATIVE ANALYSIS; RISK REDUCTION; SENSITIVITY ANALYSIS; SMOKING; SYSTEMATIC REVIEW; ADULT; AGED; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; DOSE RESPONSE; FEMALE; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; ODDS RATIO; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; HUMANS; LIGNANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85019597768     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kww207     Document Type: Article

References (59)

1. Rio D, Costa LG, Lean ME, et al. Polyphenols and health: what compounds are involved? Nutr Metab Cardiovasc Dis. 2010;20(1):1-6
2. Rio D, Rodriguez-Mateos A, Spencer JP, et al. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal. 2013;18(14):1818-1892
3. Grosso G, Buscemi S, Galvano F, et al. Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects. BMC Surg. 2013;13(suppl 2):S14
4. Grosso G, Mistretta A, Frigiola A, et al. Mediterranean diet and cardiovascular risk factors: a systematic review. Crit Rev Food Sci Nutr. 2014;54(5):593-610
5. Arranz S, Chiva-Blanch G, Valderas-Martínez P, et al. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients. 2012;4(7):759-781
6. Bøhn SK, Blomhoff R, Paur I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res. 2014;58(5):915-930
7. Visioli F, Davalos A. Polyphenols and cardiovascular disease: a critical summary of the evidence. Mini Rev Med Chem. 2011; 11(14):1186-1190
8. Ravishankar D, Rajora AK, Greco F, et al. Flavonoids as prospective compounds for anti-cancer therapy. Int J Biochem Cell Biol. 2013;45(12):2821-2831
9. Costanzo S, Di Castelnuovo A, DonatiMB, et al.Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol. 2011;26(11):833-850
10. Wang X, Ouyang YY, Liu J, et al. Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies. Br J Nutr. 2014;111(1):1-11
11. van Dam RM, Naidoo N, Landberg R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr Opin Lipidol. 2013; 24(1):25-33
12. Woo HD, Kim J. Dietary flavonoid intake and risk of stomach and colorectal cancer. World J Gastroenterol. 2013;19(7): 1011-1019
13. Zamora-Ros R, Agudo A, Luján-Barroso L, et al. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2012;96(6):1398-1408
14. Woo HD, Kim J. Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLoS One. 2013;8(9):e75604
15. Adlercreutz H. Lignans and human health. Crit Rev Clin Lab Sci. 2007;44(5-6):483-525
16. Ionkova I. Anticancer lignans-from discovery to biotechnology. Mini Rev Med Chem. 2011;11(10):843-856
17. Peterson J, Dwyer J, Adlercreutz H, et al. Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev. 2010;68(10):571-603
18. Costanzo S, Di Castelnuovo A, Donati MB, et al. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2010;55(13): 1339-1347
19. Di Castelnuovo A, Costanzo S, Bagnardi V, et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166(22):2437-2445
20. Grosso G, Yang J, Marventano S, et al. Nut consumption on all-cause, cardiovascular, and cancer mortality risk: a systematic review and meta-analysis of epidemiologic studies. Am J Clin Nutr. 2015;101(4):783-793
21. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/ clinical-epidemiology/oxford.asp. Published 1999. Accessed April 26, 2016
22. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301-1309
23. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6(1):40-57
24. Orsini N, Li R, Wolk A, et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1): 66-73
25. Knekt P, Jarvinen R, Reunanen A, et al. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ. 1996; 312(7029):478-481
26. Rimm EB, Katan MB, Ascherio A, et al. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 1996;125(5):384-389
27. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet. 1997;349(9053):699
28. Hertog MG, Sweetnam PM, Fehily AM, et al. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr. 1997;65(5): 1489-1494
29. Arts IC, Hollman PC, Feskens EJ, et al. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr. 2001;74(2):227-232
30. Arts IC, Jacobs DR Jr, Harnack LJ, et al. Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology. 2001;12(6):668-675
31. Hirvonen T, Pietinen P, Virtanen M, et al. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology. 2001;12(1):62-67
32. Geleijnse JM, Launer LJ, Van der Kuip DA, et al. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002;75(5):880-886
33. Knekt P, Kumpulainen J, Järvinen R, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76(3):560-568
34. Nagata C, Takatsuka N, Shimizu H. Soy and fish oil intake and mortality in a Japanese community. Am J Epidemiol. 2002; 156(9):824-831
35. Milder IE, Feskens EJ, Arts IC, et al. Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen Elderly Study. AmJ Clin Nutr. 2006;84(2): 400-405
36. Kokubo Y, Iso H, Ishihara J, et al. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 2007;116(22):2553-2562
37. Lin J, Rexrode KM, Hu F, et al. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol. 2007;165(11):1305-1313
38. Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. AmJ Clin Nutr. 2007;85(3): 895-909
39. Mursu J, Voutilainen S, Nurmi T, et al. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2008;100(4):890-895
40. McCullough ML, Peterson JJ, Patel R, et al. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012;95(2):454-464
41. Ivey KL, Lewis JR, Prince RL, et al. Tea and non-tea flavonol intakes in relation to atherosclerotic vascular disease mortality in older women. Br J Nutr. 2013;110(9):1648-1655
42. Zamora-Ros R, Jiménez C, Cleries R, et al. Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology. 2013;24(5):726-733
43. Talaei M, Koh WP, van Dam RM, et al. Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr. 2014;144(6):921-928
44. Tresserra-Rimbau A, Rimm EB, Medina-Remón A, et al. Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial. BMC Med. 2014;12:77
45. Ivey KL, Hodgson JM, Croft KD, et al. Flavonoid intake and all-cause mortality. Am J Clin Nutr. 2015;101(5):1012-1020
46. Ponzo V, Goitre I, Fadda M, et al. Dietary flavonoid intake and cardiovascular risk: a population-based cohort study. J Transl Med. 2015;13:218
47. Wang X, Ouyang Y, Liu J, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 2014;349: g4490
48. Shrime MG, Bauer SR,McDonald AC, et al. Flavonoid-rich cocoa consumption affectsmultiple cardiovascular risk factors in ametaanalysis of short-term studies.JNutr. 2011;141(11):1982-1988
49. Yamasaki K, Kayaba K, Ishikawa S. Soy and soy products intake, all-cause mortality, and cause-specific mortality in Japan: the Jichi Medical School Cohort Study. Asia Pac J Public Health. 2015;27(5):531-541
50. Kim A, Chiu A, Barone MK, et al. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc. 2011; 111(11):1720-1729
51. Tokede OA, Gaziano JM, Djoussé L. Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. Eur J Clin Nutr. 2011;65(8):879-886
52. Wang ZM, Zhao D, Nie ZL, et al. Flavonol intake and stroke risk: ameta-analysis of cohort studies. Nutrition. 2014;30(5):518-523
53. Cassidy A, O'Reilly ÉJ, Kay C, et al. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011;93(2):338-347
54. Sohrab G, Hosseinpour-Niazi S, Hejazi J, et al. Dietary polyphenols and metabolic syndrome among Iranian adults. Int J Food Sci Nutr. 2013;64(6):661-667
55. Hui C, Qi X, Qianyong Z, et al. Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One. 2013;8(1):e54318
56. Chen M, Rao Y, Zheng Y, et al. Association between soy isoflavone intake and breast cancer risk for pre-and postmenopausal women: a meta-analysis of epidemiological studies. PLoS One. 2014;9(2):e89288
57. van Die MD, Bone KM, Williams SG, et al. Soy and soy isoflavones in prostate cancer: a systematic review and metaanalysis of randomized controlled trials. BJU Int. 2014; 113(5):E119-E130
58. Wu SH, Liu Z. Soy food consumption and lung cancer risk: a meta-analysis using a common measure across studies. Nutr Cancer. 2013;65(5):625-632
59. Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr. 2005;81(1 suppl):292S-297S